2019 Bioelectronic Medicine Forum
April 4, 2019
Millenium Broadway, New York, NY
Tentative Agenda
8:00-8:30 |
Registration and Coffee |
8:30-8:45 |
Overview of the Bioelectronic Medicine IndustryJames Cavuoto, Editor and Publisher, Neurotech ReportsNeurotech Business Report Editor James Cavuoto presents an overview of the bioelectronic medicine industry, including key players, technological roots, and market projections. |
8:45-9:15 |
Keynote AddressSue Siegel, Chief Innovation Officer, CEO, GE VenturesThis keynote session features observations from a major investor and innovator in the medical device industry. |
9:15-10:00 |
Investment in Bioelectronic MedicineImran Eba, Partner, Action Potential Venture Capital, ModeratorEvan Norton, Divisional Vice President, Abbott VenturesJeff Erb, Senior Director, Business Development, MedtronicEric Van Gieson, Ph.D., Program Manager, DARPAIn this session, investment professionals active in the life sciences industry will offer their views on the investment climate for bioelectronic medicine. |
10:00-10:30 |
Refreshment Break |
10:30-11:15 |
Entrepreneur Panel IJames Cavuoto, Editor and Publisher, Neurotech Reports, ModeratorThomas Oxley, M.D., Ph.D., CEO and Founder, Synchron Inc.Gaurev Sharma, Ph.D., Technical Leader in Neuromodulation, BattelleJacob Zabara, Ph.D., President, Jacob Zabara Family FoundationPresentations from executives of emerging bioelectronic medicine firms. |
11:15-12:00 |
New Devices Up Our Sleeve: Neuromodulation Gets PersonalJennifer French, Senior Editor, Neurotech Reports, ModeratorMarom Bikson, Ph.D., Director, Neural Engineering Laboratory, CCNYShai Gozani, M.D., Ph.D., President and CEO, Neurometrix Inc.Bioelectronic medicine now incorporates new wearable diagnostic, therapeutic, and software devices and vendors are exploring new distribution channels and revenue models. In this session, we'll discuss trends in digital health, direct-to-consumer marketing, and pay-per-dose pricing. |
12:00-1:30 |
Luncheon |
1:30-2:15 |
Regulatory and Reimbursement IssuesJeremy Koff, Senior Contributing Editor, Neurotech Reports, ModeratorVictor Pikov, Ph.D., CEO, Medipace, Inc.,Startup and established bioelectronic medicine firms face a variety of regulatory and reimbursement issues on the way to commercialization. In this closing session, we'll explore key considerations in designing clinical trials, obtaining FDA approval, and getting reimbursement from payors. |
2:15-3:00 |
Entrepreneur Panel IIJames Cavuoto, Editor, Neurotech Reports, ModeratorJennifer Ernst, CEO, Tivic HealthDon Deyo, CEO, FemPulse LLCSamuel Hamner, Ph.D., Director of Technology and Product Marketing, Cala HealthPresentations from executives of emerging bioelectronic medicine firms. |
3:00-3:30 |
Refreshment Break |
3:30-4:15 |
Entrepreneur Panel IIIJames Cavuoto, Editor, Neurotech Reports, ModeratorDaniel Powell, CEO, Spark BiomedicalDouglas Adams, CEO, Qura Inc.Bill Edelman, CEO, Highland InstrumentsPresentations from executives of emerging bioelectronic medicine firms. |
4:15-5:00 |
Future Outlook for Bioelectronic MedicineJames Cavuoto, Editor and Publisher, Neurotech Reports, ModeratorKip Ludwig, Ph.D., Director, Bioelectronic Medicines Laboratory, University of WisconsinElliot Krames, M.D., Former President, International Neuromodulation SocietyJeff Kramer, Ph.D., Vice-President, Research and Technology, Medtronic plcIn this closing session, we'll look at new applications for bioelectronic medicine, including potential therapies for treating immunological, dematalogical, and hematalogical disorders. |
5:00-7:00 |
Cocktail Reception |